General Information of the Compound
Compound ID
CP0541725
Compound Name
N-[4-bromo-5-(4-tert-butylphenyl)-1H-pyrazol-3-yl]-2-chlorobenzamide
    Show/Hide
Structure
Formula
C20H19BrClN3O
Molecular Weight
432.749
Canonical SMILES
CC(C)(C)c1ccc(cc1)-c1n[nH]c(NC(=O)c2ccccc2Cl)c1Br
    Show/Hide
InChI
InChI=1S/C20H19BrClN3O/c1-20(2,3)13-10-8-12(9-11-13)17-16(21)18(25-24-17)23-19(26)14-6-4-5-7-15(14)22/h4-11H,1-3H3,(H2,23,24,25,26)
    Show/Hide
InChIKey
VTOZEOCALIQLJJ-UHFFFAOYSA-N
Physicochemical Property
logP
6.0424
Rotatable Bonds
3
Heavy Atom Count
26
Polar Areas
57.78
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
2
Complexity
26

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 2818985
ChEMBL ID
CHEMBL244522
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01032, B1 bradykinin receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000411 IMR-90 Homo sapiens (Human)  1
1
IC50 = 3200 nM
   TI
   LI
   LO
   TS